Last updated on September 2018

A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma

Brief description of study

To collect and store blood and biopsy samples obtained from CD or UC patients exposed to adalimumab and diagnosed with Hepatosplenic T-cell Lymphoma (HSTCL), for the purpose of identifying potential biomarkers and genetic mutations in patients who have developed HSTCL.

Detailed Study Description

A study to bank samples for future evaluation to identify genetic mutations and other biomarkers that predispose inflammatory bowel disease (IBD) patients to developing Hepatosplenic T-cell Lymphoma (HSTCL).

Clinical Study Identifier: NCT02087878

Contact Investigators or Research Sites near you

Start Over

Andrea Byars

United States, Illinois
North Chicago, IL United States
  Connect »